Alector (ALEC) Cash from Financing Activities (2018 - 2026)
Alector's (ALEC) quarterly Cash from Financing Activities came in at $25000.0 in Q1 2026, down 99.54% on a QoQ basis from $5.4 million in Q4 2025.
Alector (ALEC) Cash from Financing Activities (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Cash from Financing Activities data on file, last reported at $25000.0 in Q1 2026.
- On a quarterly basis, Cash from Financing Activities changed N/A year-over-year to $25000.0 in Q1 2026; TTM through Mar 2026 was $20.2 million, a 94.02% increase from a year earlier, with the FY2025 full-year figure at $20.2 million, down 75.21% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $25000.0, down from $5.4 million in the prior quarter.
- Over the last five years, Cash from Financing Activities for ALEC reached as high as $71.1 million in Q1 2024 and fell as low as $25000.0 in Q1 2026.
- Historically, Cash from Financing Activities has averaged $7.8 million across 5 years, with a median of $893500.0 in 2022.
- Across the five-year window, Cash from Financing Activities plunged 96.7% in 2022 and soared 6490.18% in 2024, its largest moves.
- Year by year, Cash from Financing Activities stood at $636000.0 in 2022, then declined by 7.23% to $590000.0 in 2023, then surged by 1558.98% to $9.8 million in 2024, then slumped by 44.91% to $5.4 million in 2025, then slumped by 99.54% to $25000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were $25000.0 in Q1 2026, $5.4 million in Q4 2025, and $14.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 30.14 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 68.63 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 9,311.16 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -538.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -802.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 238.74 Mn |
| 10 | Alector | 164.78 Mn | -41.74 Mn | - | 25,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25,000.00 |
| Mar 31, 2026 | 25,000.00 |
| Dec 31, 2025 | 5.39 Mn |
| Dec 31, 2025 | 5.39 Mn |
| Sep 30, 2025 | 14.70 Mn |
| Sep 30, 2025 | 14.70 Mn |
| Jun 30, 2025 | 122,000.00 |
| Jun 30, 2025 | 122,000.00 |
| Dec 31, 2024 | 9.79 Mn |
| Dec 31, 2024 | 9.79 Mn |
| Jun 30, 2024 | 644,000.00 |
| Jun 30, 2024 | 644,000.00 |
| Mar 31, 2024 | 71.11 Mn |
| Mar 31, 2024 | 71.11 Mn |
| Dec 31, 2023 | 590,000.00 |
| Dec 31, 2023 | 590,000.00 |
| Jun 30, 2023 | 881,000.00 |
| Jun 30, 2023 | 881,000.00 |
| Mar 31, 2023 | 1.08 Mn |
| Mar 31, 2023 | 1.08 Mn |